SG
StoneX Group’s Pfizer PFE Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $995K | Sell |
41,061
-50,462
| -55% | -$1.22M | 0.05% | 329 |
|
2025
Q1 | $2.32M | Buy |
91,523
+15,127
| +20% | +$383K | 0.13% | 148 |
|
2024
Q4 | $2.03M | Buy |
+76,396
| New | +$2.03M | 0.11% | 167 |
|
2022
Q2 | – | Sell |
-38,244
| Closed | -$1.98M | – | 682 |
|
2022
Q1 | $1.98M | Buy |
38,244
+3,536
| +10% | +$183K | 0.19% | 105 |
|
2021
Q4 | $2.05M | Buy |
34,708
+10,387
| +43% | +$613K | 0.24% | 88 |
|
2021
Q3 | $1.05M | Sell |
24,321
-3,260
| -12% | -$140K | 0.15% | 147 |
|
2021
Q2 | $1.08M | Buy |
27,581
+3,051
| +12% | +$119K | 0.16% | 138 |
|
2021
Q1 | $889K | Buy |
24,530
+3,006
| +14% | +$109K | 0.16% | 133 |
|
2020
Q4 | $792K | Buy |
21,524
+5,251
| +32% | +$193K | 0.17% | 123 |
|
2020
Q3 | $597K | Buy |
16,273
+3,362
| +26% | +$123K | 0.19% | 130 |
|
2020
Q2 | $422K | Sell |
12,911
-943
| -7% | -$30.8K | 0.16% | 169 |
|
2020
Q1 | $452K | Sell |
13,854
-1,122
| -7% | -$36.6K | 0.24% | 118 |
|
2019
Q4 | $587K | Buy |
14,976
+2,722
| +22% | +$107K | 0.24% | 125 |
|
2019
Q3 | $440K | Buy |
12,254
+1,114
| +10% | +$40K | 0.27% | 126 |
|
2019
Q2 | $483K | Buy |
11,140
+261
| +2% | +$11.3K | 0.31% | 100 |
|
2019
Q1 | $462K | Buy |
10,879
+2,067
| +23% | +$87.8K | 0.35% | 94 |
|
2018
Q4 | $385K | Buy |
8,812
+1,540
| +21% | +$67.3K | 0.37% | 92 |
|
2018
Q3 | $320K | Sell |
7,272
-213
| -3% | -$9.37K | 0.24% | 155 |
|
2018
Q2 | $272K | Buy |
7,485
+576
| +8% | +$20.9K | 0.23% | 170 |
|
2018
Q1 | $245K | Buy |
6,909
+592
| +9% | +$21K | 0.23% | 173 |
|
2017
Q4 | $229K | Sell |
6,317
-193
| -3% | -$7K | 0.24% | 174 |
|
2017
Q3 | $232K | Sell |
6,510
-49,571
| -88% | -$1.77M | 0.29% | 143 |
|
2017
Q2 | $1.88M | Buy |
56,081
+45,777
| +444% | +$1.54M | 0.59% | 40 |
|
2017
Q1 | $335K | Sell |
10,304
-185
| -2% | -$6.02K | 0.75% | 48 |
|
2016
Q4 | $341K | Buy |
+10,489
| New | +$341K | 0.6% | 65 |
|